• Author: Isla P. Garraway
Clear all

Tumor suppressor genes, treatments, and survival in US Veterans with prostate cancer

Abstract: BACKGROUND: Tumor suppressor gene (TSG) alterations prognosticate inferior survival in metastatic hormone-sensitive prostate cancer (mHSPC) and may affect response to …

Genomic risk model to implement precision prostate cancer screening in clinical care: The ProGRESS study

Abstract: Precision healthcare aims to tailor disease prevention and early detection to individual risk. Prostate cancer screening may benefit from genomics-informed approaches. We …

Prostate cancer incidence and outcomes among Vietnam Veterans receiving care in the Veterans Health Administration

Abstract: BACKGROUND: Agent Orange exposure (AOE) is considered a presumptive cause of prostate cancer (PCa) in the Veterans Affairs (VA) population; however, cohort studies …

Somatic tumor next-generation sequencing in US Veterans with metastatic prostate cancer

Abstract: IMPORTANCE: National guidelines recommend next-generation sequencing (NGS) of tumors in patients diagnosed with metastatic prostate cancer (mPCa) to identify potential …

Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System

Abstract: Prostate cancer (PCa) disproportionately affects African American men, but research evaluating the extent of racial and ethnic disparities across the PCa continuum in …